Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Trial
Phase 1 Escalating Single-dose Safety, Tolerability, and Pharmacokinetics of SQ109 in Healthy Volunteers
Study Director
Start Date
0 / 0
Trial Phase
Trial Status
published
Current Enrollment
62
Target Enrollment
62
Overview
Compound Associations
SQ109